ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 87 filers reported holding ALLOVIR INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,786,377 | -48.0% | 830,873 | -17.8% | 0.00% | 0.0% |
| Q2 2023 | $3,437,835 | -14.8% | 1,011,128 | -1.2% | 0.00% | 0.0% |
| Q1 2023 | $4,033,800 | -19.8% | 1,023,807 | +4.4% | 0.00% | -50.0% |
| Q4 2022 | $5,030,760 | -23.7% | 980,655 | +17.3% | 0.00% | 0.0% |
| Q3 2022 | $6,594,000 | +117.0% | 835,779 | +7.3% | 0.00% | +100.0% |
| Q2 2022 | $3,039,000 | -42.6% | 779,168 | -0.7% | 0.00% | -50.0% |
| Q1 2022 | $5,299,000 | -46.4% | 785,020 | +2.8% | 0.00% | -33.3% |
| Q4 2021 | $9,877,000 | -48.7% | 763,329 | -0.7% | 0.00% | -50.0% |
| Q3 2021 | $19,270,000 | +59.6% | 768,948 | +25.7% | 0.01% | +50.0% |
| Q2 2021 | $12,072,000 | -15.9% | 611,552 | -0.3% | 0.00% | 0.0% |
| Q1 2021 | $14,353,000 | -40.5% | 613,355 | -2.3% | 0.00% | -50.0% |
| Q4 2020 | $24,131,000 | +42.4% | 627,755 | +1.9% | 0.01% | +33.3% |
| Q3 2020 | $16,942,000 | – | 616,089 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 6,597,167 | $14,184 | 0.61% |
| GMT CAPITAL CORP | 4,211,283 | $9,054,258 | 0.34% |
| Redmile Group, LLC | 1,907,969 | $4,102,133 | 0.20% |
| WASATCH ADVISORS LP | 6,319,871 | $13,587,723 | 0.09% |
| SVB FINANCIAL GROUP | 17,207 | $36,995 | 0.07% |
| Regency Capital Management Inc.\DE | 30,025 | $64,554 | 0.06% |
| Samsara BioCapital, LLC | 82,336 | $177,022 | 0.05% |
| Woodline Partners LP | 2,066,666 | $4,443,332 | 0.05% |
| XTX Topco Ltd | 84,049 | $180,705 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 65,450 | $140,718 | 0.03% |